CPT® Code 90712

Deleted

The poliovirus vaccine, identified by CPT® Code 90712, is a live vaccine administered orally to provide active immunity against poliovirus. Unlike immune globulins, which offer short-term, passive immunity, vaccines like this one stimulate the recipient's immune system to produce its own antibodies. This process involves exposing the immune system to a weakened form of the poliovirus, which is known as an attenuated virus. The immune system responds by generating antibodies that can recognize and combat the actual virus if encountered in the future. The primary purpose of this vaccine is to prevent poliomyelitis, a potentially debilitating disease caused by the poliovirus. The oral poliovirus vaccine (OPV) is specifically designed to trigger a robust immune response while ensuring that the individual does not develop the disease itself, as the live virus is not virulent enough to cause illness. It is important to note that this code specifically reports the use of any type of live poliovirus vaccine for oral administration, distinguishing it from other types of poliovirus vaccines, such as the inactivated poliovirus vaccine (IPV), which is administered via subcutaneous or intramuscular routes and is reported under CPT® Code 90713. The focus of this code is solely on the vaccine product itself, rather than the administration or clinical context in which it is used.